Antacid therapy and Tongue discoloration
Tongue discoloration is reported only by a few people with Antacid therapy.
The study analyzes which people have Tongue discoloration with Antacid therapy. It is created by eHealthMe based on 4 people who have Tongue discoloration and Antacid therapy from the Food and Drug Administration (FDA), and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
4 people who have Antacid Therapy and Tongue Discoloration are studied.
What is Antacid therapy?
Antacid therapy: no further information found.
What is Tongue discoloration?
Tongue discoloration is found to be associated with 1,047 drugs and 545 conditions by eHealthMe.
Number of Tongue discoloration in Antacid therapy reports submitted per year:
Gender of people who have Antacid Therapy and experienced Tongue Discoloration *:
- female: 100 %
- male: 0.0 %
Age of people who have Antacid Therapy and experienced Tongue Discoloration *:
- 0-1: 100 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 0.0 %
Common co-existing conditions for these people *:
- Vitamin E Deficiency: 2 people, 50.00%
- Vitamin A Deficiency: 2 people, 50.00%
- Serum Ferritin Decreased: 2 people, 50.00%
- Musculoskeletal Pain (pain affects the bones, muscles, ligaments, tendons, and nerves): 2 people, 50.00%
- Hypokalemia (low potassium): 2 people, 50.00%
- Hypocalcaemia (levels of calcium in blood serum are abnormally low): 2 people, 50.00%
- Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 2 people, 50.00%
- Nerve Injury: 1 person, 25.00%
- Arthritis (form of joint disorder that involves inflammation of one or more joints): 1 person, 25.00%
Common drugs taken by these people *:
- Paracetamol: 2 people, 50.00%
- Nexium: 1 person, 25.00%
- Gabapentin: 1 person, 25.00%
- Celebrex: 1 person, 25.00%
Common symptoms for these people *:
- Lip Swelling: 2 people, 50.00%
- Diarrhea: 2 people, 50.00%
- Tooth Discoloration (a change in colour of teeth): 1 person, 25.00%
- Taste - Impaired: 1 person, 25.00%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Tongue discoloration?Check whether Tongue discoloration is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Treatments, associated drugs and conditions:
COVID vaccines that are related to Tongue discoloration:
- Tongue discoloration in Moderna COVID Vaccine
- Tongue discoloration in Pfizer BioNTech Covid Vaccine
- Tongue discoloration in Johnson and Johnson Covid Vaccine
Common drugs associated with Tongue discoloration:
- Aspirin: 248 reports
- Prednisone: 210 reports
- Humira: 171 reports
- Omeprazole: 170 reports
- Spiriva: 149 reports
- Metformin: 148 reports
- Methotrexate: 144 reports
- Enbrel: 135 reports
- Nexium: 135 reports
- Fosamax: 134 reports
All the drugs that are associated with Tongue discoloration:
- Tongue discoloration (1,047 drugs)
Common conditions associated with Tongue discoloration:
- High blood pressure: 252 reports
- Rheumatoid arthritis: 182 reports
- Chronic obstructive pulmonary disease: 181 reports
- Asthma: 168 reports
- High blood cholesterol: 154 reports
- Depression: 141 reports
- Osteoporosis: 133 reports
- Pain: 132 reports
- Multiple sclerosis: 107 reports
- Stress and anxiety: 105 reports
All the conditions that are associated with Tongue discoloration:
- Tongue discoloration (545 conditions)
How the study uses the data?
The study is based on Tongue discoloration and Antacid therapy, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Urinary Tract Infection and Bell'S Palsy - 4 seconds ago
- Prezista and Omeprazole drug interaction - 6 seconds ago
- Aptivus and Prezista drug interaction - 10 seconds ago
- Vitamin B5 and Metformin drug interaction - 10 seconds ago
- Prezista and Prednisolone drug interaction - 16 seconds ago
- Dapsone and Prezista drug interaction - 16 seconds ago
- Alprazolam and Prezista drug interaction - 17 seconds ago
- Lortab and Ejection Fraction Abnormal - 27 seconds ago
- Vitamin D and Zomacton drug interaction - 31 seconds ago
- Prezista and Zerit drug interaction - 37 seconds ago